Determining priority signs and symptoms for use as clinical outcomes assessments in trials including patients with malignant gliomas: Panel 1 Report

Terri S. Armstrong, Allison M. Bishof, Paul D. Brown, Martin Klein, MJB Taphoorn, Christina Theodore-Oklota

Research output: Contribution to JournalArticleAcademicpeer-review

20 Citations (Scopus)
Original languageEnglish
Pages (from-to)1-12
JournalNeuro-Oncology
Volume18
DOIs
Publication statusPublished - Mar 2016

Keywords

  • clinical outcomes assessment
  • glioblastoma
  • glioma
  • outcomes
  • signs and symptoms

Cite this